EP2348032 - Bibliographic data
6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester comme agent anti-inflammatoire
| Last update | 21/07/2025 |
|---|---|
| Legal status | Invention expirée |
| Origin | Européen |
| (73) Holder |
GLAXO GROUP LIMITED 980 Great West Road
TW8 9GS s
BRENTFORD, MIDDLESEX
Royaume-Uni
|
|---|---|
| (72) Inventors |
Keith Biggadike GlaxoSmithKline
Gunnels Wood Road
Stevenage, Hertfordshire SG1 2NY
Royaume-Uni
Steven Coote GlaxoSmithKline
Gunnells Wood Road
Stevenage, Hertfordshire SG1 2NY
Royaume-Uni
Rosalyn Nice c/o GlaxoSmithKline,
9890 Great West Road,
Brentford, Middlesex, TW8 9 GS
Royaume-Uni
|
| (74) Agent |
Mail recipient Cabinet José CURAU 17, rue Basse
98000
MONACO
Principauté de Monaco
|
| (21) Request number | EP10179104.4 |
|---|---|
| (22) Request date | 03/08/2001 |
| (11) Publication number | EP2348032 |
|---|---|
| Publication date | 15/07/2015 |
| (54) Title of the invention | 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester comme agent anti-inflammatoire |
|---|---|
| (51) International classification | C07J 31/00, A61K 31/58, A61P 5/44 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 0019172 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity | None |
|---|---|
| Last annuity | Annuity: 20 - Payment date 28/07/2020 |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2015/35, of 28/08/2015 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 15/07/2015 Constitution de mandataire pour un dossier - Legal date 05/08/2015 Expiration de l'invention - Legal date 04/08/2021 |